Loading...

VRNA VERONA PHARMA PLC Capital Structure Changes 8-K Filing

VRN

VRN

VERONA PHARMA PLC

(VRNA)

2025 8-K

Show Summary

Show Summary

Financial Statements

Credit Agreement Amendment

Financial Results

Financial Results

Financial Results

Financial Results Announcement

Financial Results

Financial Results Announcement

Management Changes

Term Loan Facility

Dismissal of Independent Au...

Results of Operations and F...

Other Special Situation

Sublease Agreement and Dire...

Financial Results Announcement

Earnings Reports

AGM Approval of Incentive A...

Financial Results Announcement

External Links:

On March 27, 2025, Verona Pharma, Inc. amended its credit agreement, increasing loan commitments from $75 million to $125 million and reducing the interest rate from 11% to 9.7%. Additionally, on March 25, 2025, the company exercised a buy-out option

AI Assistant

VERONA PHARMA PLC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.